Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Neoadjuvant Chemotherapy Followed by Radical Hysterectomy for the Treatment of Locally Advanced Cervical Cancer: A Prospective Cohort Study

NCT03963882 is registered in ClinicalTrials.gov with Lei Li as lead sponsor.

NCT NCT03963882
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03963882 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Neoadjuvant Chemotherapy Followed by Radical Hysterectomy for the Treatment of Locally Advanced Cervical Cancer: A Prospective Cohort Study
Lead sponsor
Lei Li
Phase
Phase 2
Overall status
Unknown status
Start date
June 19, 2019
Completion date
June 1, 2025
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adjuvant therapy, concurrent chemoradiotherapy, laparoscopy, laparotomy, locally advanced cervical cancer, neoadjuvant chemotherapy, objective response, radical hysterectomy, systematic chemotherapy